Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study

Background. The duration of protection against tuberculosis provided by isoniazid preventive therapy is not known for human immunodeficiency virus (HIV)-infected individuals living in settings of medium tuberculosis incidence. Methods. We conducted an individual-level analysis of participants in a c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Golub, Jonathan E., Cohn, Silvia, Saraceni, Valeria, Cavalcante, Solange C., Pacheco, Antonio G., Moulton, Lawrence H., Durovni, Betina, Chaisson, Richard E.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366579/
https://ncbi.nlm.nih.gov/pubmed/25365974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu849
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars